NCT02854644View on ClinicalTrials.gov

Study of the Anti-tumoral Immune Response

NACompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

January 27, 2014

Primary Completion Date

October 27, 2021

Study Completion Date

October 27, 2021

Conditions
Breast CancerGlioma
Interventions
OTHER

additional blood sample

Trial Locations (1)

25030

Centre Hospitalier Régional Universitaire, Besançon

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT02854644 - Study of the Anti-tumoral Immune Response | Biotech Hunter | Biotech Hunter